Colistimethate Sodium

6 trials 4 recruiting JAnti-infectives

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

4 Recruiting

1 Completed trials

6 Sponsors

6 Countries

Phase III

Phase II

Phase IV

Phase III: 1 Phase II: 3 Phase IV: 2

Oversight events:

1 temporary halt across 1 trial

View oversight register →

Indications tested

Sepsis 2 Abdominal infection 1 Infection 1 Bronchiectasis 1 Bacterial infection 1 Urinary tract infection 1

Sponsors using this IMP

Centre Hospitalier Intercommunal Creteil 1 Consorci Mar Parc De Salut De Barcelona 1 Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla 1 Hellenic Institute For The Study Of Sepsis 1 Pfizer Inc. 1 Philipps-Universitaet Marburg 1

All trials

6 total

PHARMACOLOGICAL STRATEGIES OF INHALED ANTIBIOTHERAPY IN BRONCHIECTASIS WITH CHRONIC BRONCHIAL INFECTION: BRONCHIPHARMA STUDY. Pending

2023-510220-72-00 Phase IV 1 country Consorci Mar Parc De Salut De Barcelona
Efficacy and safety of 7 versus 14 days of antibiotic treatment for bacteremia produced by Pseudomonas aeruginosa: a multicenter, randomized… Recruiting

2023-508441-41-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
Comparison of Two Antibiotic Regimens for the Treatment of Early Airways Infection With PA in Adults With Bronchiectasis Recruiting

2023-504755-26-00 Phase II 1 country Centre Hospitalier Intercommunal Creteil
A Study of Aztreonam-Avibactam (ATM-AVI) Compared to Best Available Therapy in Pediatric Participants with Serious Gram-Negative Bacterial C… Recruiting

2022-501575-12-00 Phase II 4 countries Pfizer Inc.
Inhalation therapy in adult bronchiectasis patients with new asymptomatic Pseudomonas aeruginosa infection– an open-label, proof of concept … Recruiting

2023-509277-22-00 Phase II 1 country Philipps-Universitaet Marburg
A RANDOMIZED PROSPECTIVE CLINICAL TRIAL TO ASSESS PROCALCITONIN-GUIDANCE AND MOLECULAR-GUIDED DIAGNOSIS AS MAINSTAY FOR THERAPY OF SEVERE IN… Ended

2022-502962-26-00 Phase III 1 country Hellenic Institute For The Study Of Sepsis

Showing 1–6 of 6 trials

← All drugs A–Z